Metagenomi, Inc Common Stock

Quarterly Financials

Values in thousands 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Revenue
$9,614
$11,514
$20,008
$11,159
Gross Profit
9,614
11,514
18,699
9,886
EBITDA
-19,162
-21,019
-15,554
-27,759
EBIT
-20,623
-22,383
-16,863
-29,032
Net Income
-23,398
-18,773
-10,739
-25,148
Net Change In Cash
9,614
11,514
20,008
11,159
Free Cash Flow
-26,610
-27,838
-26,974
-30,765
Cash
27,386
25,117
61,181
102,558
Basic Shares
37,432
36,766
37,459
21,137

Annual Financials

Values in thousands 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Revenue
$52,295
$44,756
$17,200
$243
Gross Profit
52,295
-49,647
15,467
-144
EBITDA
-83,494
-74,285
-39,193
-20,753
EBIT
-88,901
-78,492
-40,926
-21,140
Net Income
-78,058
-68,255
-43,593
-21,442
Net Change In Cash
52,295
44,756
17,200
243
Free Cash Flow
-112,187
-101,223
15,747
21,354
Cash
27,386
140,603
184,441
39,296
Basic Shares
37,432
37,472
37,472
37,472

Earnings Calls

Quarter EPS
2024-12-31
-$0.63
2024-09-30
-$0.51
2024-06-30
-$0.29
2024-03-31
-$1.19